End Tidal Carbon Monoxide (ETCO): - A Tool to Aid Identification of Neonatal Hemolysis

Sponsor

Cedars-Sinai Medical Center (Other)

Overall Status

Not yet recruiting

CT.gov ID

NCT05475223

Collaborator

(none)

350

Enrollment

Arm

5.1

Anticipated Duration (Months)

Study Details

Study Description

Brief Summary

The purpose of this study is to evaluate if adding a noninvasive testing of End Tidal Carbon Monoxide with a FDA approved device will help improve management of jaundice in the Neonates by reducing the number of lab draws, Coombs tests and optimizing the number of phototherapy hours in Neonates who need it.

Eligible subjects will be Term and healthy late preterm newborns born at Cedars-Sinai Medical Center and admitted to well baby nursery from November 2020 onwards.

The primary procedure of measuring an End-Tidal Carbon monoxide in a Newborn is going to be with a soft cannula applied to the Newborn's nose for a few minutes. The whole procedure will take about 15+ 5 minutes.

Subject participation will last approximately 6 months and all subjects will be followed up with one phone call at about 2-4 weeks of age.

Adding ETCO testing to current standard of care might reduce the number of lab draws in a newborn and potentially reduce costs by optimizing the number of phototherapy hours in a Newborn who needs it. Cedars- Sinai Medical Center will not be billing the patients for the End-Tidal Carbon Monoxide measurement for this study.

Condition or Disease	Intervention/Treatment	Phase
End Tidal Carbon Monoxide Excretion as a Diagnostic Tool for Hemolysis in the Newborn Neonatal Jaundice End Tidal Carbon Monoxide	Diagnostic Test: End Tidal Carbon Monoxide Value	N/A

Detailed Description

The purpose the research is:

Whether near simultaneous measurements of Total Serum bilirubin (Tsb) & End-Tidal Carbon Monoxide (End-Tidal Carbon monoxide as a function of bilirubin) will help identify hyperbilirubinemia accurately and easily This has been shown in a single center study.
Whether near simultaneous measurement of Total serum bilirubin & End Tidal Carbon Monoxide is more accurate and less costly in overall management of Neonatal Hyperbilirubinemia Eligible infants would be male or female with GA > 35 weeks and BW > 2000, post natal age 6 hours to < 6 days of age and meets any one of the following criteria
Due for an early discharge
Has a Transcutaneous bilirubin or a Total serum bilirubin on or > the 75th % of Bhutani hyperbilirubinemia nomogram
Has 2 or more risk factors for neonatal jaundice as specified in the protocol
The study includes 388 patients in each arm - ~ 776 total newborn admissions
The total study duration is: 6 months Methods: a retrospective group (Standard of Care) will be compared with a prospective Group (Standard of care + End-Tidal Carbon monoxide). Informed Consent will be obtained before the subject is recruited in the prospective group.

A phone call will be made to each subject in the prospective group at 2-4 weeks of age post birth hospitalization. This is a minimally risk study.

Study Design

Study Type:

Interventional

Anticipated Enrollment :

350 participants

Allocation:

N/A

Intervention Model:

Single Group Assignment

Intervention Model Description:

Retrospective review of subjects for Standard of Care for Neonatal jaundice diagnosis and management (SOC) will be compared with a prospective group of subjects with Standard of care for Neonatal jaundice for diagnosis and management + End Tidal Carbon Monoxide management (ETCO)Retrospective review of subjects for Standard of Care for Neonatal jaundice diagnosis and management (SOC) will be compared with a prospective group of subjects with Standard of care for Neonatal jaundice for diagnosis and management + End Tidal Carbon Monoxide management (ETCO)

Masking:

None (Open Label)

Primary Purpose:

Diagnostic

Official Title:

End Tidal Carbon Monoxide (ETCO) : A Tool to Aid Identification of Neonatal Hemolysis

Anticipated Study Start Date :

Jul 29, 2022

Anticipated Primary Completion Date :

Dec 31, 2022

Anticipated Study Completion Date :

Dec 31, 2022

Arms and Interventions

Arm	Intervention/Treatment
Other: Prospective Standard of Care for Diagnosis and management of neonatal jaundice + End Tidal Carbon Monoxide measurement value	Diagnostic Test: End Tidal Carbon Monoxide Value A noninvasive ETCO value will be obtained by inserting a soft silicon cannula placed in the baby's nostril for a few minutes to measure exhaled end tidal carbon monoxide; a value corrected for ambient ETCO value will be recorded.

Arm

Intervention/Treatment

Other: Prospective

Standard of Care for Diagnosis and management of neonatal jaundice + End Tidal Carbon Monoxide measurement value

Diagnostic Test: End Tidal Carbon Monoxide Value

A noninvasive ETCO value will be obtained by inserting a soft silicon cannula placed in the baby's nostril for a few minutes to measure exhaled end tidal carbon monoxide; a value corrected for ambient ETCO value will be recorded.

Outcome Measures

Primary Outcome Measures

Change in usage of Coombs Test and other Labs Ordered for hemolysis in Neonatal Jaundice [6 months]
We expect a projected change of 10-15% in Coombs Test usage for neonatal jaundice and mean difference of 1 in other labs ordered for hemolysis in neonatal jaundice

Secondary Outcome Measures

Adding ETCO to diagnostic procedures for hemolysis in neonatal jaundice will help optimize phototherapy [6 months]
On average on readmission at Cedars- Sinai Medical Center a newborn gets 36 +/-10 hours of phototherapy and on birth admission some babies are getting 6 +/- 12 hours of phototherapy. ETCO (End tidal carbon monoxide value) used a function of Total serum bilirubin will help optimize the number of hours of phototherapy.
Recording of nursing time to perform the test [6 months]
The time taken by medical personnel to perform and record results will be recorded

Eligibility Criteria

Criteria

Ages Eligible for Study:

35 Weeks to 44 Weeks

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Yes

Inclusion Criteria:

male or female with GA > 35 weeks and BW > 2000, post natal age 6 hours to < 6 days of age and meets any one of the following criteria
Due for an early discharge
Has a TcB or Tsb on or > the 75th % of Bhutani hyperbilirubinemia nomogram
Has 2 or more risk factors for neonatal jaundice as specified in the protocol

Exclusion Criteria:

babies requiring any kind of respiratory support (O2, CPAP or assisted ventilation) has severe or life threatening congenital anomalies, weighed less than 2000 gms and if their mother has a known history of smoking during 3rd trimester of pregnancy. Also in addition nasal mucosal abrasion or nasal mucosal abnormalities will be excluded.